CT’s Unique Bid to Lower Cost of GLP-1 Drugs

CT to Seek Federal Approval to Make Generic GLP-1 Weight Loss Drugs

Connecticut Gov. Ned Lamont (D) signed legislation (HB 7192) allowing the state to seek to hire a generic drug-manufacturer to make cheap versions of Ozempic, Wegovy and other GLP-1 drugs the state could then provide to those covered by Medicaid or the state employees’ health plan. No other state has a law in place for such drugs (NEW HAVEN REGISTER)

—Compiled by SNCJ Managing Editor KOREY CLARK

Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.